Literature DB >> 31175983

Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Richard A Maki1, Michael Holzer2, Khatereh Motamedchaboki3, Ernst Malle4, Eliezer Masliah5, Gunther Marsche2, Wanda F Reynolds6.   

Abstract

α-Synuclein (αSyn) is central to the neuropathology of Parkinson's disease (PD) due to its propensity for misfolding and aggregation into neurotoxic oligomers. Nitration/oxidation of αSyn leads to dityrosine crosslinking and aggregation. Myeloperoxidase (MPO) is an oxidant-generating enzyme implicated in neurodegenerative diseases. In the present work we have examined the impact of MPO in PD through analysis of postmortem PD brain and in a novel animal model in which we crossed a transgenic mouse expressing the human MPO (hMPO) gene to a mouse expressing human αSyn-A53T mutant (A53T) (hMPO-A53T). Surprisingly, our results show that in PD substantia nigra, the hMPO gene is expressed in neurons containing aggregates of nitrated αSyn as well as MPO-generated HOCl-modified epitopes. In our hMPO-A53T mouse model, we also saw hMPO expression in neurons but not mouse MPO. In the mouse model, hMPO was expressed in neurons colocalizing with nitrated αSyn, carbamylated lysine, nitrotyrosine, as well as HOCl-modified epitopes/proteins. RNAscope in situ hybridization confirmed hMPO mRNA expression in neurons. Interestingly, the hMPO protein expressed in hMPO-A53T brain is primarily the precursor proMPO, which enters the secretory pathway potentially resulting in interneuronal transmission of MPO and oxidative species. Importantly, the hMPO-A53T mouse model, when compared to the A53T model, exhibited significant exacerbation of motor impairment on rotating rods, balance beams, and wire hang tests. Further, hMPO expression in the A53T model resulted in earlier onset of end stage paralysis. Interestingly, there was a high concentration of αSyn aggregates in the stratum lacunosum moleculare of hippocampal CA2 region, which has been associated in humans with accumulation of αSyn pathology and neural atrophy in dementia with Lewy bodies. This accumulation of αSyn aggregates in CA2 was associated with markers of endoplasmic reticulum (ER) stress and the unfolded protein response with expression of activating transcription factor 4 (ATF4), C/EBP homologous protein (CHOP), MPO, and cleaved caspase-3. Together these findings suggest that MPO plays an important role in nitrative and oxidative damage that contributes to αSyn pathology in synucleinopathies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha synuclein; Carbamylation; Dementia with lewy bodies; ER stress; Hippocampus CA2 region; Hypochlorous acid; MPO-H(2)O(2)-chloride system; Myeloperoxidase; Nitration; Parkinson's disease; Reactive oxygen species; Synucleinopathies; Unfolded protein response

Mesh:

Substances:

Year:  2019        PMID: 31175983      PMCID: PMC6774439          DOI: 10.1016/j.freeradbiomed.2019.05.033

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  160 in total

1.  Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.

Authors:  Alan P Kumar; F Javier Piedrafita; Wanda F Reynolds
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

Review 2.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

3.  Molecular forms of myeloperoxidase in human plasma.

Authors:  R L Olsen; T K Steigen; T Holm; C Little
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

4.  Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study.

Authors:  Sandra K Pope; Stephen B Kritchevsky; Christine Ambrosone; Kristine Yaffe; Frances Tylavsky; Eleanor M Simonsick; Caterina Rosano; Scott Stewart; Tamara Harris
Journal:  Am J Epidemiol       Date:  2006-04-26       Impact factor: 4.897

5.  Binding of NF-Y transcription factor to one of the cis-elements in the myeloperoxidase gene promoter that responds to granulocyte colony-stimulating factor.

Authors:  T Orita; K Shimozaki; H Murakami; S Nagata
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

6.  Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.

Authors:  Qingshan Wang; Li Qian; Shih-Heng Chen; Chun-Hsien Chu; Belinda Wilson; Esteban Oyarzabal; Syed Ali; Bonnie Robinson; Deepa Rao; Jau-Shyong Hong
Journal:  Brain       Date:  2015-02-25       Impact factor: 13.501

7.  SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein.

Authors:  Timothy Y Huang; Yingjun Zhao; Xiaoguang Li; Xin Wang; I-Chu Tseng; Robert Thompson; Shichun Tu; Thomas E Willnow; Yun-Wu Zhang; Huaxi Xu
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

8.  Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome.

Authors:  Rebecca A Piskorowski; Kaoutsar Nasrallah; Anastasia Diamantopoulou; Jun Mukai; Sami I Hassan; Steven A Siegelbaum; Joseph A Gogos; Vivien Chevaleyre
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

9.  Association of myeloperoxidase with ovarian cancer.

Authors:  Dan Cacsire Castillo-Tong; Dietmar Pils; Georg Heinze; Ioana Braicu; Jalid Sehouli; Alexander Reinthaller; Eva Schuster; Andrea Wolf; Rafal Watrowski; Richard A Maki; Robert Zeillinger; Wanda F Reynolds
Journal:  Tumour Biol       Date:  2013-07-27

Review 10.  The other myeloperoxidase: Emerging functions.

Authors:  Luc Vanhamme; Karim Zouaoui Boudjeltia; Pierre Van Antwerpen; Cédric Delporte
Journal:  Arch Biochem Biophys       Date:  2018-03-31       Impact factor: 4.013

View more
  11 in total

1.  Carvedilol attenuates acrylamide-induced brain damage through inhibition of oxidative, inflammatory, and apoptotic mediators.

Authors:  Keyvan Amirshahrokhi; Arezoo Abzirakan
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

2.  Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Ana Luisa Gavito; Antonio Córdoba-Fernández; José Chacón; Ángel Martín de Pablos
Journal:  Antioxidants (Basel)       Date:  2022-05-30

Review 3.  Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

4.  MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1G93A Motor Neuron of Amyotrophic Lateral Sclerosis.

Authors:  Jialing Peng; Jingrui Pan; Jingjing Mo; Ying Peng
Journal:  Oxid Med Cell Longev       Date:  2022-02-07       Impact factor: 6.543

Review 5.  Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders.

Authors:  Musbau Adewumi Akanji; Damilare Emmanuel Rotimi; Tobiloba Christiana Elebiyo; Oluwakemi Josephine Awakan; Oluyomi Stephen Adeyemi
Journal:  Oxid Med Cell Longev       Date:  2021-08-03       Impact factor: 6.543

6.  The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study.

Authors:  Chin-Song Lu; Hsiu-Chen Chang; Yi-Hsin Weng; Chiung-Chu Chen; Yi-Shan Kuo; Ying-Chieh Tsai
Journal:  Front Nutr       Date:  2021-06-30

7.  Myeloperoxidase and Septic Conditions Disrupt Sphingolipid Homeostasis in Murine Brain Capillaries In Vivo and Immortalized Human Brain Endothelial Cells In Vitro.

Authors:  Madeleine Goeritzer; Eva Bernhart; Ioanna Plastira; Helga Reicher; Christina Leopold; Thomas O Eichmann; Gerald Rechberger; Corina T Madreiter-Sokolowski; Jürgen Prasch; Philipp Eller; Wolfgang F Graier; Dagmar Kratky; Ernst Malle; Wolfgang Sattler
Journal:  Int J Mol Sci       Date:  2020-02-09       Impact factor: 5.923

Review 8.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

Review 9.  The Role of Inflammation and Myeloperoxidase-Related Oxidative Stress in the Pathogenesis of Genetically Triggered Thoracic Aortic Aneurysms.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

Review 10.  Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies.

Authors:  Gunther Marsche; Julia T Stadler; Julia Kargl; Michael Holzer
Journal:  Antioxidants (Basel)       Date:  2022-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.